Specify a stock or a cryptocurrency in the search bar to get a summary
Predilife
ALPREPredilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France. Address: 39, Rue Camille Desmoulins, Villejuif, France, 94805
Analytics
WallStreet Target Price
9.51 EURP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ALPRE
Dividend Analytics ALPRE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALPRE
Stock Valuation ALPRE
Financials ALPRE
Results | 2019 | Dynamics |